Results 201 to 210 of about 5,547,700 (265)

Frequency and Phenotype of Coexisting Aquaporin‐4 and Autoimmune Encephalitis Autoantibodies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Among 9457 aquaporin‐4 (AQP4) immunoglobulin G‐positive patients, 2071 underwent autoimmune encephalitis antibody testing and 85 (4%) had coexisting antibodies, most commonly cerebrospinal fluid glial fibrillary acidic protein‐IgG and N‐methyl‐D‐aspartate receptor‐IgG, or serum high‐titer GAD65‐IgG.
Laura Cacciaguerra   +25 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Incident Comorbid Diabetes and Outcomes in Multiple Sclerosis: An English Population‐Based Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the incidence of diabetes mellitus and its associations with hospitalisation and mortality in adults with multiple sclerosis (MS) and matched controls. Methods Using English primary care data from the Clinical Practice Research Datalink, linked to hospital and mortality records, we matched adults with MS with up to 10 ...
Yolanda Lau   +8 more
wiley   +1 more source

Assessing Symptom Burden

Clinics in Chest Medicine, 2020
Evaluating symptoms is a central part of the chronic obstructive pulmonary disease (COPD) assessment system as suggested by the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Considering the pros and cons of all currently available tests, GOLD suggests using primarily the modified Medical Research Council dyspnea scale or the COPD ...
Claus F, Vogelmeier, Peter, Alter
openaire   +2 more sources

SYMPTOM ASSESSMENT

Hematology/Oncology Clinics of North America, 1996
Medical intervention aims to eliminate disease, to mitigate disease effect, and maximize quality of life. Throughout the course of illness, accurate symptom assessment is imperative if these goals are to be achieved. Symptom scales may facilitate this process in the clinical setting.
J M, Ingham, R K, Portenoy
openaire   +2 more sources

Symptom assessment and management

Neurologic Clinics, 2001
This article reviews how to assess and manage several symptoms commonly encountered by neurologists who care for patients with advanced illness. Scientifically validated guidelines are reviewed and practical advice is offered on how to manage pain, nausea and vomiting, dyspnea, and respiratory secretions at the end of life.
A C, Carver, K M, Foley
openaire   +2 more sources

Assessing Psychologic Symptoms in Adolescents

Southern Medical Journal, 1978
Assessing the meaning of psychologic symptoms in adolescents can be a difficult task. Pediatricians, internists, and family practitioners are often the first professionals consulted by families worried that their teen-agers may be in psychologic distress.
J, Looney, D, Oldham, M, Blotcky
openaire   +2 more sources

Memorial Symptom Assessment Scale

Expert Review of Pharmacoeconomics & Outcomes Research, 2004
Patients with advanced illnesses often have multiple symptoms. As interest in palliative care and interventions for symptom control increase, the ability to assess multiple symptoms has become more important. A number of instruments have been developed to meet this need in cancer patients.
Victor T, Chang   +4 more
openaire   +2 more sources

Categorizing and assessing negative symptoms

Current Opinion in Psychiatry, 2017
To provide a review on studies published in the last year relevant to the categorization and assessment of negative symptoms.Recent research supported the validity of the 'deficit/non-deficit schizophrenia' categorization. Few studies confirmed the validity of the category 'persistent negative symptoms', whereas no recent study explored the validity of
BUCCI, Paola, GALDERISI, Silvana
openaire   +2 more sources

A Questionnaire for The Assessment of Biliary Symptoms

American Journal of Gastroenterology, 2003
Gallstone disease is common and causes high health care costs, but a measure of symptomatic biliary disease for outcome studies is lacking. We aimed to develop a reproducible, valid, discriminative, disease-specific measure of biliary symptoms.We created the self-report Biliary Symptoms Questionnaire (BSQ) by combining possible biliary symptoms with ...
Yvonne, Romero   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy